to study this hypothesis , we randomly assigned adolescents with newly diagnosed iddm to receive either conventional treatment ( n = 14 ) ( nph insulin , 1 u per kilogram of body weight per day , in two divided doses ) or an experimental treatment ( n = 12 ) ( a two-week hospitalization with maintenance of blood glucose levels between 3.3 and 4.4 mmol per liter by continuous insulin infusion delivered by an external artificial pancreas [ biostator ] ) .
C0011854
iddm
C0021641
insulin